Posted by Michael Wonder on 03 Jun 2024
Teva announces Austedo XR (deutetrabenazine) extended release tablets now US FDA approved as a one pill, once daily treatment option for clinically therapeutic doses (24 mg–48 mg/day)
29 May 2024 - US FDA approves new one pill, once daily Austedo XR tablets (30 mg, 36 mg, 42 mg, 48 mg/day).
Teva Pharmaceuticals today announced that the US FDA has approved Austedo XR as a one pill, once daily treatment option, now with four new tablet strengths (30 mg, 36 mg, 42 mg, 48 mg) indicated in adults for tolerable tardive dyskinesia and Huntington’s disease chorea.
